Edition:
United States

Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

26.70USD
4:00pm EDT
Change (% chg)

$-0.20 (-0.74%)
Prev Close
$26.90
Open
$26.95
Day's High
$26.95
Day's Low
$26.25
Volume
82,004
Avg. Vol
161,487
52-wk High
$32.15
52-wk Low
$11.85

Chart for

About

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20... (more)

Overall

Beta: 1.75
Market Cap(Mil.): $2,106.67
Shares Outstanding(Mil.): 78.31
Dividend: --
Yield (%): --

Financials

  MNTA.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -1.81 -- --
ROI: -35.63 1.50 12.72
ROE: -40.97 0.19 14.85

Amphastar cannot collect $100 mln during Momenta drug patent appeal - judge

A federal judge on Monday ruled that Amphastar Pharmaceuticals Inc must wait to collect a $100 million bond that Momenta Pharmaceuticals Inc and Sandoz Inc posted in a drug patent case it won until after an appellate court hears the dispute.

Jul 16 2018

BRIEF-Momenta Pharmaceuticals Q1 Loss Per Share $0.63

* MOMENTA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 08 2018

Competitors

Earnings vs. Estimates